BLRX - BioLineRx Ltd. (BLRX) CEO Philip Serlin on Q4 2021 Results - Earnings Call Transcript
Call Start: 10:00 Call End: 10:31 BioLineRx Ltd. (BLRX) Q4 2021 Earnings Conference Call March 16, 2022 10:00 ET CompanyParticipants Tim McCarthy - LifeSci Advisors, IR Philip Serlin - Chief Executive Officer Mali Zeevi - Chief Financial Officer Ella Sorani - Chief Development Officer Abi Vainstein-Haras - Chief Medical Officer Conference Call Participants Joseph Pantginis - H.C. Wainwright & Co. John Vandermosten - Zacks Investment Research Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Fourth Quarter 2021 Conference Call. All participants are presently in a listen-only mode. Following management’s formal presentation instructions will be given for the question-and-answer session. [Operator Instructions] I would now like to turn the call over to Tim McCarthy of LifeSci Advisors. Please go ahead. Tim McCarthy Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. All statements
For further details see:
BioLineRx Ltd. (BLRX) CEO Philip Serlin on Q4 2021 Results - Earnings Call Transcript